Evidence map›Paper›PMID 32313281›Full record

ArticleAmerican journal of pharmaceutical education2020

Is It Time for a Quality Rating System for Colleges of Pharmacy?

David P Nau, Benjamin Aronson, Terri Warholak

Abstract readComment
In one paragraph

Article in American journal of pharmaceutical education, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. 2020 rankings for US PharmD programs, research, and overall quality.Exploratory research in clinical and social pharmacy · 2022
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

David P NauUniversity of Wyoming, School of Pharmacy, Laramie, Wyoming.
Benjamin AronsonOhio Northern University, Raabe College of Pharmacy, Ada, Ohio.
Terri WarholakUniversity of Arizona, College of Pharmacy, Tucson, Arizona.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The quality of educational programs, including Doctor of Pharmacy (PharmD) programs, has largely escaped the societal trend towards public reporting. Recent criticisms of pharmacy academia by practitioners should prompt us to reexamine how the quality of pharmacy education is measured and reported to the public. In supporting greater transparency related to quality, important questions that should be addressed include: Is the current public reporting of quality indicators for pharmacy schools sufficient for determining the quality of education provided by a school? Can a quality rating system be developed that will not only provide a valid assessment of quality, but also be easy to interpret by potential applicants and employers? The intent of this commentary is to initiate a discussion centered around this issue and to encourage the development of a new measure of pharmacy school quality.

Indexed as

Education, PharmacyPharmaceutical ServicesPharmaciesStudents, PharmacyHumansSchools, PharmacyNorth American Pharmacist Licensure Examinationqualityrankings

Identifiers

PMID32313281
PMCPMC7159012

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.